Showing results (351-360 of 518) with videos related to

Sort By:
Pageof 52
AJNR. American Journal of Neuroradiology|February 19, 2011
Differentiation between glioblastomas, solitary brain metastases, and primary cerebral lymphomas using diffusion tensor and dynamic susceptibility contrast-enhanced MR imagingS Wang, S Kim, S Chawla, et al.
Frontiers in Immunology|June 4, 2019
Unusual Cysteine Content in V1 Region of gp120 From an Elite Suppressor That Produces Broadly Neutralizing AntibodiesJennie M Hutchinson, Kathryn A Mesa, David L Alexander, et al.
Clinical Neurology and Neurosurgery|May 19, 2019
The LACE+ index fails to predict 30-90 day readmission for supratentorial craniotomy patients: A retrospective series of 238 surgical proceduresIan F Caplan, Patricia Zadnik Sullivan, Gregory Glauser, et al.
Experimental and Molecular Pathology|October 2, 2012
Reversion of the ErbB malignant phenotype and the DNA damage responseE Aaron Runkle, Hongtao Zhang, Zheng Cai, et al.
World Neurosurgery|March 31, 2019
LACE+ Index as Predictor of 30-Day Readmission in Brain Tumor PopulationIan F Caplan, Patricia Zadnik Sullivan, David Kung, et al.
American Journal of Clinical Oncology|December 1, 1991
High-dose 24-hour infusion of 5-fluorouracil in metastatic prostate cancer. A phase II trial of the Piedmont Oncology AssociationJ N Atkins, H B Muss, D Case, et al.
BMJ Open|February 7, 2021
Psychometric properties and use of the DEMQOL suite of instruments in research: a systematic review protocolMatthias Hoben, Stephanie A Chamberlain, Hannah M O'Rourke, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 23, 2021
Enhancing CAR T function with the engineered secretion of C. perfringens neuraminidaseJoseph S Durgin, Radhika Thokala, Lexus Johnson, et al.
European Radiology|February 15, 2015
Association of dynamic susceptibility contrast enhanced MR Perfusion parameters with prognosis in elderly patients with glioblastomasPejman Jabehdar Maralani, Elias R Melhem, Sumei Wang, et al.
Epidemiology and Infection|February 5, 2024
Immune response to SARS-CoV-2 variants after immunization with different vaccines in MexicoErika Garay, Sean P J Whelan, Rebecca M DuBois, et al.
Pageof 52